Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of SPM962 Transdermal Patch in Restless Legs Syndrome
jRCT2080221020Phase 3
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Feb 2010
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in restless legs syndrome (RLS) (3 arms), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on jRCT2080221020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221020.